Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice

被引:215
作者
Miyaji, T
Hu, XZ
Yuen, PST
Muramatsu, Y
Iyer, S
Hewitt, SM
Star, RA
机构
[1] NIDDK, Renal Diagnost & Therapeut Unit, NIH, Bethesda, MD 20892 USA
[2] NCI, Pathol Lab, CCR, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
acute renal failure; inflammation; TNF-alpha; coagulation; lipopolysaccharide;
D O I
10.1046/j.1523-1755.2003.00268.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Sepsis is a common cause of acute renal failure (ARF). The incidence of sepsis increases dramatically after 50 years of age; however, most ARF studies are performed in young mice. Methods. We performed two common sepsis models, lipopolysaccharide (LPS) administration and cecal ligation puncture (CLP) in aged mice. We developed a fully treated CLP model in aged mice by treating mice with fluid resuscitation and antibiotics. Results. LPS induced renal injury in aged but not young mice. However, volume resuscitation starting within 6 hours decreased renal injury. We then used this fluid resuscitation scheme, along with antibiotics, to develop a fully treated CLP model in aged mice. Mice subjected to CLP developed functional and histologic ARF and multiple organ damage. Treatment with ethyl pyruvate, even when started 12 hours after surgery, decreased serum creatinine, tubular damage, and multiple organ injury at 24 hours. Ethyl pyruvate decreased plasma tumor necrosis factor-alpha (TNF-alpha), and kidney mRNA for TNFalpha, tissue factor, and plasminogen activator inhibitor-1 (PAI-1), and increased mRNA for urokinase-like plasminogen activator. Conclusion. CLP in aged mice causes functional and histologic changes consistent with human ARF. A single dose of ethyl pyruvate inhibits renal and multiple organ damage, and is still effective when given 12 hours after surgery.
引用
收藏
页码:1620 / 1631
页数:12
相关论文
共 60 条
  • [1] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [2] Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study
    Arlati, S
    Brenna, S
    Prencipe, L
    Marocchi, A
    Casella, GP
    Lanzani, M
    Gandini, C
    [J]. INTENSIVE CARE MEDICINE, 2000, 26 (01) : 31 - 37
  • [3] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [4] Bacterial sepsis-induced rhabdomyolysis
    Betrosian, A
    Thireos, E
    Kofinas, G
    Balla, M
    Papanikolaou, M
    Georgiadis, G
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (05) : 469 - 474
  • [5] TREM-1 amplifies inflammation and is a crucial mediator of septic shock
    Bouchon, A
    Facchetti, F
    Weigand, MA
    Colonna, M
    [J]. NATURE, 2001, 410 (6832) : 1103 - 1107
  • [6] Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study
    Brivet, FG
    Kleinknecht, DJ
    Loirat, P
    Landais, PJM
    Bedock, B
    Bleichner, G
    Richard, C
    Coste, F
    BrunBuisson, C
    Sicot, C
    Tenaillon, A
    Gajdos, P
    Blin, F
    Saulnier, F
    Agostini, MM
    Nicolas, F
    FeryLemonnier, E
    Staikowski, F
    Carlet, J
    Guivarch, G
    Fraisse, F
    Ricome, J
    Tempe, JD
    Mezzarobba, P
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (02) : 192 - 198
  • [7] alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats
    Chiao, H
    Kohda, Y
    McLeroy, P
    Craig, L
    Housini, I
    Star, RA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) : 1165 - 1172
  • [8] INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
    Cohen, J
    Carlet, J
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (09) : 1431 - 1440
  • [9] Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney
    Cunningham, PN
    Dyanov, HM
    Park, P
    Wang, J
    Newell, KA
    Quigg, RJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (11) : 5817 - 5823
  • [10] Targeting high mobility group box 1 as a late-acting mediator of inflammation
    Czura, CJ
    Tracey, KJ
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : S46 - S50